» Articles » PMID: 28239489

Insights from Molecular Dynamics Simulations for Computational Protein Design

Overview
Date 2017 Feb 28
PMID 28239489
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

A grand challenge in the field of structural biology is to design and engineer proteins that exhibit targeted functions. Although much success on this front has been achieved, design success rates remain low, an ever-present reminder of our limited understanding of the relationship between amino acid sequences and the structures they adopt. In addition to experimental techniques and rational design strategies, computational methods have been employed to aid in the design and engineering of proteins. Molecular dynamics (MD) is one such method that simulates the motions of proteins according to classical dynamics. Here, we review how insights into protein dynamics derived from MD simulations have influenced the design of proteins. One of the greatest strengths of MD is its capacity to reveal information beyond what is available in the static structures deposited in the Protein Data Bank. In this regard simulations can be used to directly guide protein design by providing atomistic details of the dynamic molecular interactions contributing to protein stability and function. MD simulations can also be used as a virtual screening tool to rank, select, identify, and assess potential designs. MD is uniquely poised to inform protein design efforts where the application requires realistic models of protein dynamics and atomic level descriptions of the relationship between dynamics and function. Here, we review cases where MD simulations was used to modulate protein stability and protein function by providing information regarding the conformation(s), conformational transitions, interactions, and dynamics that govern stability and function. In addition, we discuss cases where conformations from protein folding/unfolding simulations have been exploited for protein design, yielding novel outcomes that could not be obtained from static structures.

Citing Articles

Compounds Inhibit MtrCDE Efflux Pump Transport Protein for the Potential Management of Gonorrhoea Infection.

Mulaudzi V, Adeosun I, Adewumi A, Soliman M, Cosa S Int J Mol Sci. 2025; 25(24.

PMID: 39769078 PMC: 11677219. DOI: 10.3390/ijms252413310.


In Silico Hybridization and Molecular Dynamics Simulations for the Identification of Candidate Human MicroRNAs for Inhibition of Virulent Proteins' Expression in Staphylococcus aureus.

Tiwari H, Saha S, Ghosh M J Cell Biochem. 2024; 126(1):e30684.

PMID: 39655425 PMC: 11735889. DOI: 10.1002/jcb.30684.


In-silico and in-vitro studies to identify potential inhibitors of SARS-CoV-2 spike protein from Omani medicinal plants.

Al-Mahrami N, Nair S, Al Mawali A, Beema Shafreen R, Ullah S, Ahsan Halim S Heliyon. 2024; 10(21):e39649.

PMID: 39553680 PMC: 11564015. DOI: 10.1016/j.heliyon.2024.e39649.


Use of genomics & proteomics in studying lipase producing microorganisms & its application.

Majumder D, Dey A, Ray S, Bhattacharya D, Nag M, Lahiri D Food Chem (Oxf). 2024; 9:100218.

PMID: 39281291 PMC: 11402113. DOI: 10.1016/j.fochms.2024.100218.


Sequence-Based Protein Design: A Review of Using Statistical Models to Characterize Coevolutionary Traits for Developing Hybrid Proteins as Genetic Sensors.

Kinshuk S, Li L, Meckes B, Chan C Int J Mol Sci. 2024; 25(15).

PMID: 39125888 PMC: 11312098. DOI: 10.3390/ijms25158320.


References
1.
Storch E, Daggett V, Atkins W . Engineering out motion: introduction of a de novo disulfide bond and a salt bridge designed to close a dynamic cleft on the surface of cytochrome b5. Biochemistry. 1999; 38(16):5054-64. DOI: 10.1021/bi982158q. View

2.
Storch E, Grinstead J, Campbell A, Daggett V, Atkins W . Engineering out motion: a surface disulfide bond alters the mobility of tryptophan 22 in cytochrome b5 as probed by time-resolved fluorescence and 1H NMR experiments. Biochemistry. 1999; 38(16):5065-75. DOI: 10.1021/bi982159i. View

3.
Kulkarni N, Shendye A, Rao M . Molecular and biotechnological aspects of xylanases. FEMS Microbiol Rev. 1999; 23(4):411-56. DOI: 10.1111/j.1574-6976.1999.tb00407.x. View

4.
Kinet S, Bernichtein S, Kelly P, Martial J, Goffin V . Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites. J Biol Chem. 1999; 274(37):26033-43. DOI: 10.1074/jbc.274.37.26033. View

5.
Apweiler R, Hermjakob H, Sharon N . On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta. 1999; 1473(1):4-8. DOI: 10.1016/s0304-4165(99)00165-8. View